Literature DB >> 12719557

Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus.

Kensuke Hirasawa1, Angus Kim, Hye-Seung Han, Jaeseok Han, Hee-Sook Jun, Ji-Won Yoon.   

Abstract

Cellular phosphorylation events during viral infection are necessary for effective viral replication. Encephalomyocarditis (EMC) virus has been used for studies on the molecular mechanisms of viral replication, but little is known about the cellular signaling pathways involved. This investigation was initiated to determine whether mitogen-activated protein kinases (MAPKs), which are central components of signal transduction pathways in the regulation of cell proliferation, play a role in the replication of EMC virus. We examined the phosphorylation of MAPKs, including extracellular signal-regulated kinase (ERK1/2), p38 MAPK, and stress-activated protein kinase 1/c-Jun NH(2)-terminal kinase (SAPK/JNK) in EMC virus-infected L929 cells and found that p38 MAPK and SAPK-JNK, but not ERK1/2, were activated during viral infection. We then examined the effect of these kinases on the replication of EMC virus in L929 cells by using specific inhibitors, including genistein or herbimycin A for tyrosine kinase, SB203580 or SB202190 for p38 MAPK, and PD98059 for ERK1/2. We found that the tyrosine kinase and p38 MAPK inhibitors, but not the ERK1/2 inhibitor, suppressed viral replication and that the inhibitory effect was primarily on viral protein synthesis. Finally, we examined whether p38 MAPK is involved in the translation of EMC viral transcripts by using L929 cells transfected with a gene construct containing the internal ribosomal entry site (IRES) of EMC virus and a luciferase reporter gene. We found that the p38 MAPK inhibitor suppressed the translation of EMC viral RNA. On the basis of these observations, we conclude that p38 MAPK plays a critical role in the replication of EMC virus, probably in the translation of viral RNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719557      PMCID: PMC154047          DOI: 10.1128/jvi.77.10.5649-5656.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A cell cycle-dependent protein serves as a template-specific translation initiation factor.

Authors:  E V Pilipenko; T V Pestova; V G Kolupaeva; E V Khitrina; A N Poperechnaya; V I Agol; C U Hellen
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

Review 2.  Organization and regulation of mitogen-activated protein kinase signaling pathways.

Authors:  T P Garrington; G L Johnson
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

3.  The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.

Authors:  P Liu; K Aitken; Y Y Kong; M A Opavsky; T Martino; F Dawood; W H Wen; I Kozieradzki; K Bachmaier; D Straus; T W Mak; J M Penninger
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication.

Authors:  M Huber; K A Watson; H C Selinka; C M Carthy; K Klingel; B M McManus; R Kandolf
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes.

Authors:  C L Manthey; S W Wang; S D Kinney; Z Yao
Journal:  J Leukoc Biol       Date:  1998-09       Impact factor: 4.962

6.  Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages.

Authors:  K Hirasawa; H S Jun; H S Han; M L Zhang; M D Hollenberg; J W Yoon
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1.

Authors:  G Zachos; B Clements; J Conner
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

8.  Acute infection of Sindbis virus induces phosphorylation and intracellular translocation of small heat shock protein HSP27 and activation of p38 MAP kinase signaling pathway.

Authors:  T Nakatsue; I Katoh; S Nakamura; Y Takahashi; Y Ikawa; Y Yoshinaka
Journal:  Biochem Biophys Res Commun       Date:  1998-12-09       Impact factor: 3.575

9.  Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor.

Authors:  W Popik; P M Pitha
Journal:  Virology       Date:  1998-12-05       Impact factor: 3.616

10.  Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection.

Authors:  S M Rodems; D H Spector
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  33 in total

1.  Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

Authors:  Wei-Choong Ch'ng; Noraini Abd-Aziz; Meng-Hua Ong; Eric J Stanbridge; Norazizah Shafee
Journal:  Cell Oncol (Dordr)       Date:  2015-05-01       Impact factor: 6.730

2.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

3.  Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.

Authors:  Xiaoning Si; Honglin Luo; Andrew Morgan; Jingchun Zhang; Jerry Wong; Ji Yuan; Mitra Esfandiarei; Guang Gao; Caroline Cheung; Bruce M McManus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125.

Authors:  Sabrina Marozin; Jennifer Altomonte; Sibylle Apfel; Phat X Dinh; Enrico N De Toni; Antonia Rizzani; Andreas Nüssler; Nobuyuki Kato; Roland M Schmid; Asit K Pattnaik; Oliver Ebert
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

6.  Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.

Authors:  Joshua C Johnson; Osvaldo Martinez; Anna N Honko; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  Antiviral Res       Date:  2014-05-09       Impact factor: 5.970

7.  Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step.

Authors:  John W A Rossen; Janneke Bouma; Rolien H C Raatgeep; Hans A Büller; Alexandra W C Einerhand
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral Myocarditis.

Authors:  Zhu Shijie; Junji Moriya; Jun'ichi Yamakawa; Rui Chen; Takashi Takahashi; Hiroyuki Sumino; Takeshi Nakahashi; Kunimitsu Iwai; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-24       Impact factor: 2.629

9.  Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.

Authors:  Sherri L Christian; Thaddeus W Collier; Dong Zu; Maria Licursi; Chris M Hough; Kensuke Hirasawa
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.

Authors:  Xiangrong Gao; Haoran Wang; Takeshi Sairenji
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.